Does Providing Laboratory Confirmed STI Results Impact Uptake of HIV Pre-exposure Prophylaxis (PrEP) Uptake Among Kenyan Adolescents Girls and Young Women? A Descriptive Analysis

Overview

Journal Sex Transm Infect

Specialty Infectious Diseases

Date 2020 Sep 12

PMID 32917766

Citations 5

Authors

Lynda Myra Oluoch

Alison Roxby

Nelly Mugo

Anna Wald

Kenneth Ngure

Stacy Selke

Bhavna Chohan

Catherine Kiptinness

Kenneth Tapia

Murugi Micheni

Stephen Gakuo Maina

Edinah Casmir

Affiliations

Soon will be listed here.

Citing Articles

Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster-randomized trial.

Roberts S, Hartmann M, Minnis A, Otticha S, Browne E, Montgomery E J Int AIDS Soc. 2023; 26(12):e26198.

PMID: 38123866 PMC: 10733161. DOI: 10.1002/jia2.26198.

Integration of sexually transmitted infection and HIV pre-exposure prophylaxis services in sub-Saharan Africa: a scoping review.

Anand P, Wu L, Mugwanya K Front Reprod Health. 2023; 5:944372.

PMID: 37457431 PMC: 10338918. DOI: 10.3389/frph.2023.944372.

Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).

Ngure K, Friedland B, Szydlo D, Roberts S, Garcia M, Levy L PLoS One. 2023; 18(6):e0287525.

PMID: 37352296 PMC: 10289422. DOI: 10.1371/journal.pone.0287525.

A Scoping Review of Oral Pre-exposure Prophylaxis for Cisgender and Transgender Adolescent Girls and Young Women: What Works and Where Do We Go from Here?.

Dayton R, Fonner V, Plourde K, Sanyal A, Arney J, Orr T AIDS Behav. 2023; 27(10):3223-3238.

PMID: 37119401 PMC: 10148005. DOI: 10.1007/s10461-023-04043-x.

Dynamic Perceived HIV Risk and Sexual Behaviors Among Young Women Enrolled in a PrEP Trial in Kenya: A Qualitative Study.

Ngure K, Thuo N, Ogello V, Kiptinness C, Kamolloh K, Burns B Front Reprod Health. 2022; 3:637869.

PMID: 36304002 PMC: 9580724. DOI: 10.3389/frph.2021.637869.

References

Baeten J, Donnell D, Ndase P, Mugo N, Campbell J, Wangisi J . Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012; 367(5):399-410. PMC: 3770474. DOI: 10.1056/NEJMoa1108524. View

Corneli A, Wang M, Agot K, Ahmed K, Lombaard J, Van Damme L . Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP. J Acquir Immune Defic Syndr. 2014; 67(5):555-63. DOI: 10.1097/QAI.0000000000000362. View

Cohen M, Council O, Chen J . Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy. J Int AIDS Soc. 2019; 22 Suppl 6:e25355. PMC: 6715951. DOI: 10.1002/jia2.25355. View

Mugwanya K, Pintye J, Kinuthia J, Abuna F, Lagat H, Begnel E . Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya. PLoS Med. 2019; 16(9):e1002885. PMC: 6719826. DOI: 10.1371/journal.pmed.1002885. View